Levodopa (administration & dosage) < Levodopa (adverse effects) < Levodopa (antagonists & inhibitors)

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 123.
[40-60] [0 - 20][0 - 50][60-80]

Ident.	Authors (with country if any)	Title
000480 (2004)	M. Bouhaddi [France] ; F. Vuillier ; J O Fortrat ; S. Cappelle ; M T Henriet ; L. Rumbach ; J. Regnard	Impaired cardiovascular autonomic control in newly and long-term-treated patients with Parkinson's disease: involvement of L-dopa therapy.
000506 (????)	O. Rascol [France] ; D J Brooks ; E. Melamed ; W. Oertel ; Werner Poewe ; F. Stocchi ; E. Tolosa	Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial.
000517 (2005)		Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect.
000521 (2005)	C. Guigoni [France] ; I. Aubert ; Q. Li ; V V Gurevich ; J L Benovic ; S. Ferry ; U. Mach ; H. Stark ; L. Leriche ; K. H Kansson ; Bernard H. Bioulac ; Christian E. Gross ; Pierre Sokoloff ; Gilberto Fisone ; E V Gurevich ; Bertrand Bloch ; Erwan Bezard	Pathogenesis of levodopa-induced dyskinesia: focus on D1 and D3 dopamine receptors.
000560 (2005)	Véronique Sgambato-Faure [France] ; Virginie Buggia ; François Gilbert ; Daniel Lévesque ; Alim-Louis Benabid ; François Berger	Coordinated and spatial upregulation of arc in striatonigral neurons correlates with L-dopa-induced behavioral sensitization in dyskinetic rats.
000566 (2006)	Jean-Pierre Wolf [France] ; Malika Bouhaddi ; Francis Louisy ; Andrei Mikehiev ; Laurent Mourot ; Sylvie Cappelle ; Fabrice Vuillier ; Pierre Andre ; Lucien Rumbach ; Jacques Regnard	Side-effects of L-dopa on venous tone in Parkinson's disease: a leg-weighing assessment.
000569 (2005)	M. Péchevis [France] ; C E Clarke ; P. Vieregge ; B. Khoshnood ; C. Deschaseaux-Voinet ; G. Berdeaux ; M. Ziegler	Effects of dyskinesias in Parkinson's disease on quality of life and health-related costs: a prospective European study.
000582 (2006)	Gilles Fénelon [France] ; Christopher G. Goetz ; Axel Karenberg	Hallucinations in Parkinson disease in the prelevodopa era.
000642 (2006)	Olivier Rascol [France] ; David J. Brooks ; Amos D. Korczyn ; Peter P. De Deyn ; Carl E. Clarke ; Anthony E. Lang ; Mona Abdalla	Development of dyskinesias in a 5-year trial of ropinirole and L-dopa.
000841 (2008)	Erwan Bezard [France]	[Striatal proteomic analysis suggests that first L-dopa dose equates to chronic exposure].
000850 (2008)	Dominique Guehl [France] ; Pierre Burbaud ; Christian Lorenzi ; Christophe Ramos ; Bernard Bioulac ; Catherine Semal ; Laurent Demany	Auditory temporal processing in Parkinson's disease.
000918 (2008)	Agnès Nadjar [France] ; Charles R. Gerfen [États-Unis] ; Erwan Bezard [France]	Priming for L-dopa-induced dyskinesia in Parkinson’s disease: a feature inherent to the treatment or the disease?
000935 (2009)	Alain Destée [France] ; Karin Rérat ; Isabelle Bourdeix	Is there a difference between levodopa/ dopa-decarboxylase inhibitor and entacapone and levodopa/dopa-decarboxylase inhibitor dose fractionation strategies in Parkinson's disease patients experiencing symptom re-emergence due to wearing-off? The Honeymoon Study.
000948 (????)	A. Annic [France] ; D. Devos ; D. Seguy ; K. Dujardin ; A. Destée ; L. Defebvre	[Continuous dopaminergic stimulation by Duodopa in advanced Parkinson's disease: Efficacy and safety].
000967 (2009)	Joëlle Micallef [France] ; Marc Rey [France] ; Alexandre Eusebio [France] ; Christine Audebert [France] ; Frank Rouby [France] ; Elisabeth Jouve [France] ; Sophie Tardieu [France] ; Oliver Blin [France]	Antiparkinsonian drug-induced sleepiness: a double-blind placebo-controlled study of L-dopa, bromocriptine and pramipexole in healthy subjects
000977 (2009)	David Devos [France]	Patient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson's disease.
000A17 (2009)	Clemence Simonin [France] ; M. Tir ; D. Devos ; A. Kreisler ; K. Dujardin ; J. Salleron ; A. Delval ; S. Blond ; L. Defebvre ; A. Destée ; P. Krystkowiak	Reduced levodopa-induced complications after 5 years of subthalamic stimulation in Parkinson's disease: a second honeymoon.
000B09 (2009)	Céline Guigoni [France] ; Erwan Bezard	Involvement of canonical and non-canonical D1 dopamine receptor signalling pathways in L-dopa-induced dyskinesia.
000B15 (2009)	Amandine Berthet [France] ; Erwan Bezard	Dopamine receptors and L-dopa-induced dyskinesia.
000C73 (2011)	O. Rascol [France]	Drugs and drug delivery in PD: optimizing control of symptoms with pramipexole prolonged-release.
000E33 (????)	Olivier Rascol [France] ; Paolo Barone ; Madhuri Behari ; Murat Emre ; Nir Giladi ; C Warren Olanow ; Evzen Ruzicka ; Francesco Bibbiani ; David Squillacote ; Anna Patten ; Eduardo Tolosa	Perampanel in Parkinson disease fluctuations: a double-blind randomized trial with placebo and entacapone.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Levodopa (adverse effects)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Levodopa (adverse effects)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Levodopa (adverse effects)
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024